| GO:0003676 | nucleic acid binding | 31.11% (14/45) | 2.45 | 0.0 | 7e-06 |
| GO:0097159 | organic cyclic compound binding | 46.67% (21/45) | 1.78 | 0.0 | 8e-06 |
| GO:1901363 | heterocyclic compound binding | 46.67% (21/45) | 1.78 | 0.0 | 8e-06 |
| GO:0090304 | nucleic acid metabolic process | 26.67% (12/45) | 2.67 | 0.0 | 1e-05 |
| GO:0016070 | RNA metabolic process | 24.44% (11/45) | 2.82 | 0.0 | 1e-05 |
| GO:0034660 | ncRNA metabolic process | 13.33% (6/45) | 4.29 | 1e-06 | 1.5e-05 |
| GO:0034470 | ncRNA processing | 11.11% (5/45) | 4.94 | 1e-06 | 1.7e-05 |
| GO:0006139 | nucleobase-containing compound metabolic process | 26.67% (12/45) | 2.45 | 1e-06 | 2.6e-05 |
| GO:0034641 | cellular nitrogen compound metabolic process | 28.89% (13/45) | 2.22 | 2e-06 | 3.4e-05 |
| GO:0140098 | catalytic activity, acting on RNA | 13.33% (6/45) | 4.0 | 2e-06 | 3.5e-05 |
| GO:0008033 | tRNA processing | 8.89% (4/45) | 5.41 | 2e-06 | 3.5e-05 |
| GO:0046483 | heterocycle metabolic process | 26.67% (12/45) | 2.34 | 2e-06 | 3.6e-05 |
| GO:0005488 | binding | 53.33% (24/45) | 1.35 | 2e-06 | 3.7e-05 |
| GO:0006725 | cellular aromatic compound metabolic process | 26.67% (12/45) | 2.31 | 3e-06 | 3.9e-05 |
| GO:0006399 | tRNA metabolic process | 11.11% (5/45) | 4.39 | 4e-06 | 4.8e-05 |
| GO:1901360 | organic cyclic compound metabolic process | 26.67% (12/45) | 2.27 | 4e-06 | 4.8e-05 |
| GO:0006396 | RNA processing | 11.11% (5/45) | 3.91 | 1.9e-05 | 0.000216 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 22.22% (10/45) | 2.29 | 2.6e-05 | 0.000281 |
| GO:0043170 | macromolecule metabolic process | 28.89% (13/45) | 1.87 | 3e-05 | 0.000304 |
| GO:0032555 | purine ribonucleotide binding | 22.22% (10/45) | 2.26 | 3.2e-05 | 0.000308 |
| GO:0017076 | purine nucleotide binding | 22.22% (10/45) | 2.24 | 3.4e-05 | 0.000314 |
| GO:1901265 | nucleoside phosphate binding | 26.67% (12/45) | 1.94 | 4e-05 | 0.000327 |
| GO:0000166 | nucleotide binding | 26.67% (12/45) | 1.94 | 4e-05 | 0.000327 |
| GO:0140101 | catalytic activity, acting on a tRNA | 8.89% (4/45) | 4.32 | 4.5e-05 | 0.000338 |
| GO:0030554 | adenyl nucleotide binding | 20.0% (9/45) | 2.35 | 5e-05 | 0.000344 |
| GO:0017150 | tRNA dihydrouridine synthase activity | 4.44% (2/45) | 7.29 | 5.3e-05 | 0.000345 |
| GO:0032553 | ribonucleotide binding | 22.22% (10/45) | 2.2 | 4.5e-05 | 0.000346 |
| GO:0005524 | ATP binding | 20.0% (9/45) | 2.4 | 3.9e-05 | 0.000348 |
| GO:0032559 | adenyl ribonucleotide binding | 20.0% (9/45) | 2.36 | 4.9e-05 | 0.00035 |
| GO:0097367 | carbohydrate derivative binding | 22.22% (10/45) | 2.17 | 5.3e-05 | 0.000352 |
| GO:0009451 | RNA modification | 6.67% (3/45) | 5.29 | 5.7e-05 | 0.000356 |
| GO:0043168 | anion binding | 26.67% (12/45) | 1.87 | 6.6e-05 | 0.000397 |
| GO:0036094 | small molecule binding | 26.67% (12/45) | 1.83 | 8.3e-05 | 0.000488 |
| GO:0008144 | drug binding | 20.0% (9/45) | 2.21 | 0.000109 | 0.00062 |
| GO:0006807 | nitrogen compound metabolic process | 28.89% (13/45) | 1.61 | 0.000189 | 0.00105 |
| GO:0044237 | cellular metabolic process | 28.89% (13/45) | 1.5 | 0.000403 | 0.002171 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 11.11% (5/45) | 2.89 | 0.000536 | 0.002812 |
| GO:0003723 | RNA binding | 8.89% (4/45) | 3.33 | 0.000643 | 0.003283 |
| GO:0006400 | tRNA modification | 4.44% (2/45) | 5.55 | 0.000786 | 0.003908 |
| GO:0003674 | molecular_function | 64.44% (29/45) | 0.67 | 0.000926 | 0.004489 |
| GO:0044238 | primary metabolic process | 28.89% (13/45) | 1.29 | 0.001596 | 0.007552 |
| GO:0071704 | organic substance metabolic process | 28.89% (13/45) | 1.18 | 0.003209 | 0.014823 |
| GO:0031491 | nucleosome binding | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0034227 | tRNA thio-modification | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0000959 | mitochondrial RNA metabolic process | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0019104 | DNA N-glycosylase activity | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0000702 | oxidized base lesion DNA N-glycosylase activity | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0000469 | cleavage involved in rRNA processing | 2.22% (1/45) | 7.87 | 0.004272 | 0.015937 |
| GO:0016887 | ATPase activity | 6.67% (3/45) | 3.23 | 0.003969 | 0.017907 |
| GO:0043167 | ion binding | 28.89% (13/45) | 1.1 | 0.005064 | 0.018537 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 8.89% (4/45) | 2.59 | 0.004205 | 0.018539 |
| GO:0090501 | RNA phosphodiester bond hydrolysis | 2.22% (1/45) | 6.87 | 0.008526 | 0.027567 |
| GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds | 2.22% (1/45) | 6.87 | 0.008526 | 0.027567 |
| GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 2.22% (1/45) | 6.87 | 0.008526 | 0.027567 |
| GO:0043044 | ATP-dependent chromatin remodeling | 2.22% (1/45) | 6.87 | 0.008526 | 0.027567 |
| GO:0016423 | tRNA (guanine) methyltransferase activity | 2.22% (1/45) | 6.87 | 0.008526 | 0.027567 |
| GO:0030515 | snoRNA binding | 2.22% (1/45) | 6.87 | 0.008526 | 0.027567 |
| GO:0016787 | hydrolase activity | 17.78% (8/45) | 1.44 | 0.008084 | 0.029043 |
| GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 4.44% (2/45) | 3.74 | 0.009708 | 0.030876 |
| GO:0008175 | tRNA methyltransferase activity | 2.22% (1/45) | 6.29 | 0.012762 | 0.039299 |
| GO:0003682 | chromatin binding | 2.22% (1/45) | 6.29 | 0.012762 | 0.039299 |
| GO:0031072 | heat shock protein binding | 2.22% (1/45) | 5.87 | 0.016981 | 0.049168 |
| GO:0000049 | tRNA binding | 2.22% (1/45) | 5.87 | 0.016981 | 0.049168 |
| GO:0002097 | tRNA wobble base modification | 2.22% (1/45) | 5.87 | 0.016981 | 0.049168 |
| GO:0002098 | tRNA wobble uridine modification | 2.22% (1/45) | 5.87 | 0.016981 | 0.049168 |